Pitch notes

Slide 1

Slide 2

Slide 3

Slide 4

• For every isolate submitted, ETD will generate an automated report highlighting emerging AMR genes and resistance mutations for that bacteria in real-time.
• The report will present factors such as the resistance mechanism, drug class, and gene location affected.
• In addition, it will provide qualitative assessments of outbreak risk and import probability.
• This information can help public health consider whether this isolate or related samples require additional investigation.

Slide 5

• This simple first page is followed by a detailed presentation and analyses of spatiotemporal, evolutionary, and gene mobility factors, as well as resistance patterns.
• These reports can be downloaded, stored locally, and shared between public health professionals who will incorporate them into their day-to-day work.
• Public health professionals, clinicians, and veterinarians will have a more complete picture of emerging AMR in the areas where they live and work.
• Newly detected emerging resistances will also be disseminated in a publicly accessible manner. Thus, they can be fed into curated news services to reach specialists, journalists, and the wider public.

Slide 6

• The potential impact of ETD is wide-reaching, and encompasses all of one health.
• Human health, agriculture, and animal health professionals already use CARD and will greatly benefit from the additional analyses offered by ETD.
• It will greatly improve surveillance efforts, and consequently help guide antimicrobial stewardship and clinical decision-making.